< Terug naar vorige pagina


Oxidative stress and cardiovascular disease events

The present invention relates to diagnosis and/or prognosis of cardiovascular disease and cardiovascular events. A prognostic risk score in relation to the cardiovascular events, more particular after intervention, can be determined by counting the number of deregulated genes (or derived proteins) in their isolated monocytes. Deregulation means low expression of COX1 and/or COX4/1, and/or TFAM, and/or RUNX2.
Octrooi-publicatienummer: EP3110973
Bron: EPO
Jaar toekenning: 2019
Jaar van publicatie: 2019
Status: Assigned
Technologiedomeinen: Biotechnology
Gevalideerd voor IOF-sleutel: Ja